Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

ARA-290 with Alcohol Safety: Research Comparison

The table below compares ARA-290's tissue-protective mechanism, alcohol's inflammatory effects, and the interaction outcomes observed in preclinical models. Understanding these distinctions clarifies why concurrent exposure reduces measurable efficacy without

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • The table below compares ARA-290's tissue-protective mechanism, alcohol's inflammatory effects, and the interaction outcomes observed in preclinical models. Understanding these distinctions clarifies why concurrent exposure reduces measurable efficacy without producing overt toxicity.
  • Primary Mechanism
  • Innate repair receptor (IRR) agonist → JAK2/STAT3 activation → TREM-1 suppression
  • Acetaldehyde + ROS generation → NF-κB activation → pro-inflammatory cytokine release
  • Competing inflammatory signaling. ARA-290 suppresses pathways alcohol activates
  • Mechanistic antagonism without pharmacological interaction
  • Hepatic Metabolism
  • Proteolytic degradation, no CYP450 involvement
  • CYP2E1 and ADH metabolism to acetaldehyde
  • No direct metabolic competition
  • Independent clearance pathways
  • Inflammatory Markers
  • Reduces TNF-α, IL-1β, IL-6 by 40–60% in LPS models
  • Elevates TNF-α, IL-1β, IL-6 during acute intoxication and hangover
  • Alcohol exposure reduces ARA-290's cytokine suppression by 30–45%
  • Alcohol attenuates peptide anti-inflammatory efficacy
  • Hepatic Effects
  • Hepatoprotective in NASH models, reduces macrophage infiltration
  • Induces steatosis, lipid peroxidation, oxidative stress
  • Peptide hepatoprotection measurably reduced in alcohol-exposed liver tissue
  • Chronic alcohol blunts liver-specific ARA-290 benefits
  • Timing Sensitivity
  • Peak effect 2–6 hours post-administration
  • Inflammatory peak during acute intoxication (0–4 hours post-consumption)
  • Overlap during inflammatory peak reduces peptide efficacy most
  • Separating administration by ≥6 hours preserves efficacy